- Probe Amplification
- Target Amplification
- Signal Amplification
Nucleic acid testing market size was valued at USD 3.1 billion in 2022 and is poised to grow at a significant CAGR 6.3% from 2023-2029. Nucleic acid testing market report gives a comprehensive outlook on nucleic acid testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, application, end user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Nucleic acid testing market is estimated to grow at significant CAGR over the forecast years 2022-2028 due to an increase in the prevalence of certain types of cancers and infectious diseases across the globe. For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, increased in demand for early stage disease diagnosis and personalized medicine, raise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the R&D for the development of newer products is a major factor drive the global nucleic acid testing market over the forecast years. For instance, in June 2018, Grifols received FDA approval for two blood screening assays: Procleix Ultrio Elite and Procleix WNV. Procleix Ultrio Elite to detect HIV 1, Hepatitis C, Hepatitis B, and HIV 2 based on nucleic acid testing. Moreover, raise in funding for R&D also boost the market over the forecast timeframe. For instance, in 2016, The National Cancer Institute has reserved $3.9 Bn to fund the establishment of laboratories to advance research on assays for cancers of the breast, prostate, lung, and genitourinary organs.
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Nucleic acid testing market size was valued at USD 3.1 billion in 2022 and is poised to grow at a significant CAGR 6.3% from 2023-2029.
Asia-Pacific is the fastest-growing for Nucleic Acid Testing Market
1.Executive Summary |
2.Global Nucleic Acid Testing Market Introduction |
2.1.Global Nucleic Acid Testing Market - Taxonomy |
2.2.Global Nucleic Acid Testing Market - Definitions |
2.2.1.Technique |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Nucleic Acid Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Nucleic Acid Testing Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Nucleic Acid Testing Market By Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Probe Amplification |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Target Amplification |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Signal Amplification |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Nucleic Acid Testing Market By Application , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Cancer, Infectious Diseases |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Genetics |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Personalized Medicine |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Nucleic Acid Testing Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centers |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Research organizations |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Nucleic Acid Testing Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Probe Amplification |
9.1.2.Target Amplification |
9.1.3.Signal Amplification |
9.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Cancer, Infectious Diseases |
9.2.2.Genetics |
9.2.3.Personalized Medicine |
9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Diagnostic Centers |
9.3.3.Research organizations |
9.3.4.Others |
9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Probe Amplification |
10.1.2.Target Amplification |
10.1.3.Signal Amplification |
10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Cancer, Infectious Diseases |
10.2.2.Genetics |
10.2.3.Personalized Medicine |
10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Diagnostic Centers |
10.3.3.Research organizations |
10.3.4.Others |
10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Probe Amplification |
11.1.2.Target Amplification |
11.1.3.Signal Amplification |
11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Cancer, Infectious Diseases |
11.2.2.Genetics |
11.2.3.Personalized Medicine |
11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Diagnostic Centers |
11.3.3.Research organizations |
11.3.4.Others |
11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Probe Amplification |
12.1.2.Target Amplification |
12.1.3.Signal Amplification |
12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cancer, Infectious Diseases |
12.2.2.Genetics |
12.2.3.Personalized Medicine |
12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Diagnostic Centers |
12.3.3.Research organizations |
12.3.4.Others |
12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Nucleic Acid Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Probe Amplification |
13.1.2.Target Amplification |
13.1.3.Signal Amplification |
13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Cancer, Infectious Diseases |
13.2.2.Genetics |
13.2.3.Personalized Medicine |
13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Diagnostic Centers |
13.3.3.Research organizations |
13.3.4.Others |
13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.bioMeriux, Inc. |
14.2.2.Bio-rad Laboratories, Inc. |
14.2.3.Abbott Laboratories |
14.2.4.Hoffmann La Roche Ltd. |
14.2.5.Qiagen N.V. |
14.2.6.Becton, Dickinson and Company |
14.2.7.Myriad Genetics, Inc. |
14.2.8.Quest Diagnostics |
14.2.9.Hologic, Inc. |
14.2.10.Grifols S.A. |
14.2.11.Illumina, Inc. |
14.2.12.Siemens AG |
14.2.13.Gen-Probe |
14.2.14.Danaher Corporation |
14.2.15.Merck KGaA |
15. Research Methodology |
16. Appendix and Abbreviations |